Tuesday, February 26, 2013

• Alnylam to Webcast Presentation at Cowen and Company 33rd Annual Health Care ConferenceBusiness Wire (Tue, Feb 26)
• U.S. Stock Options With Biggest Changes in Implied Volatilityat Bloomberg (Tue, Feb 26)

Monday, February 25, 2013

• Biotech Bubble: Alnylam Triples Despite Setbacks And Insider Sellingat Seeking Alpha (Mon, Feb 25)

Friday, February 22, 2013

• Lightning Round: Vonage, Bank of America, Molycorp and Moreat CNBC (Fri, Feb 22)

Tuesday, February 19, 2013

• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual ReportEDGAR Online (Tue, Feb 19)

Thursday, February 14, 2013

• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Thu, Feb 14)

Wednesday, February 13, 2013

• Third Rock Ventures puts up $47M to seed cancer startupat bizjournals.com (Wed, Feb 13)

Monday, February 11, 2013

• KeyCorp Downgraded to Sell and 3 Downgraded Stocks to Followat Wall St. Cheat Sheet (Mon, Feb 11)
• Corporate Leaders Receive Thirteenth Annual Emerald Asset Management “E-3 Awards”Business Wire (Mon, Feb 11)
• Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year HighMarketwired (Mon, Feb 11)
• Alnylam downgraded to Hold from Buy at MLV Equitytheflyonthewall.com (Mon, Feb 11)

Friday, February 8, 2013

• Loss Widens at Alnylam, Sales FallZacks (Fri, Feb 8)
• Alnylam stock up on smaller than expected quarterly lossat bizjournals.com (Fri, Feb 8)

Thursday, February 7, 2013

• Alnylam Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Feb 7)
• Alnylam Pharma's 4Q loss widens on settlement costAP (Thu, Feb 7)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Results of OperatioEDGAR Online (Thu, Feb 7)
• Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2012 Financial ResultsBusiness Wire (Thu, Feb 7)

Tuesday, February 5, 2013

• Alnylam-MDCO Join for ALN-PCSZacks (Tue, Feb 5)
• Alnylam to Webcast Presentation at Upcoming Investor ConferencesBusiness Wire (Tue, Feb 5)
• Alynylam stock up on The Medicine Company’s $25M betat bizjournals.com (Tue, Feb 5)
• Over 25 Companies to Present at Emerald Groundhog Day Investment ForumBusiness Wire (Tue, Feb 5)

Monday, February 4, 2013

• A Cholesterol-Treatment Contender Partners Upat Motley Fool (Mon, Feb 4)
• Medicines Company Braces For 2015 With Alnylam PCSK9 Dealat Seeking Alpha (Mon, Feb 4)
• ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Mon, Feb 4)
• 4 Healthcare Stock Stories to Treat the Monday Bluesat Wall St. Cheat Sheet (Mon, Feb 4)

Add ALNY News to My Yahoo!